Editorial |
Molecular imprinting is a rapidly developing technique for preparing polymeric materials that are capable of high molecular recognition [1-9]. This method usually involves crosslinking of functional monomers in the presence of template molecules by radical polymerization and then, removing the target molecules. The imprinted polymers selectively bind again with the template molecules. During the last decade, application of molecular imprinting polymers (MIPs) as affinity phase in solid phase extraction, as recognition elements in sensors, as stationary phase for preparative purification or separation of enantiomers and as catalyst are being actively pursued [10-16]. Antibiotic drugs are still commonly used in medicine. In recent decade, concerns have been raised regarding the public health impact of the occurrence of antibiotics in the aquatic environments. There are indication of increased bacterial resistance in wastewater from hospital and pharmaceutical industries and this is also causing concern. |
In this editorial, molecular imprinting polymers (MIPs) possessing special binding ability to Vancomycin, Teicoplanin, Oritavancin, Telavancin and Dalbavancin are investigated (Figure 1). The results clearly indicate that synthesized molecular imprinting polymers (MIPs) possess higher Vancomycin, Teicoplanin, Oritavancin, Telavancin and Dalbavancin binding ability as compared with corresponding non– imprinted polymers. Moreover, the decrease in porogenic solvent polarity used for the synthesis of molecular imprinting polymers (MIPs) can enhance the molecular imprinting polymers (MIPs) Vancomycin, Teicoplanin, Oritavancin, Telavancin and Dalbavancin binding due to the decrease in dielectric constant. |
References |
- Flynn TR, Shanti RM (2016) Principles of Antibiotic Therapy for Head, Neck, and Orofacial Infections. In:Hupp JR, Ferneini EM (Eds), Head, Neck, and Orofacial Infections. Elsevier, St Louis.
- MurrayBE, Arias CA,Nannini EC (2015) Glycopeptides (Vancomycin and Teicoplanin), Streptogramins (Quinupristin-Dalfopristin), Lipopeptides (Daptomycin), and Lipoglycopeptides (Telavancin). In:John E. Bennett JE, Dolin R, Blaser MJ (Eds), Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. (8th Edition), Content Repository Only, Philadelphia.
- Klinker KP, Borgert SJ (2015) Beyond Vancomycin: The Tail of the Lipoglycopeptides.Clinical Therapeutics 37: 2619-2636.
- Chaudhry SB (2015) Miscellaneous Antibacterial Drugs. In: Ray SD (Eds), Side Effects of Drugs Annual. Elsevier.
- Masterton R, Cornaglia G, Courvalin P, Lode HM, Rello J, et al. (2015) The clinical positioning of telavancin in Europe. Int J Antimicrob Ag 45: 213-220.
- Mendes RE, Farrell DJ, Sader HS, Streit JM, Jones RN (2015) Update of the telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2013), when applying the revised susceptibility testing method.DiagnMicrobiol Infect Dis 81: 275-279.
- Tsoulas C, Nathwani D (2015) Review of meta-analyses of vancomycin compared with new treatments for Gram-positive skin and soft-tissue infections: Are we any clearer? Int J Antimicrob Ag46: 1-7.
- Bereczki I, Mándi A, RÃ?Â?th E, Borbás A, Fizil A, et al. (2015) A few atoms make the difference: Synthetic, CD, NMR and computational studies on antiviral and antibacterial activities of glycopeptide antibiotic aglycon derivatives.Eur J Med Chem 94: 73-86.
- Tzialla C, Borghesi A, Pozzi M, Stronati M (2015) Neonatal infections due to multi-resistant strains: Epidemiology, current treatment, emerging therapeutic approaches and prevention. ClinicaChimicaActa, 451: 71-77.
- Falcone M, Russo A, Venditti M (2015) Optimizing antibiotic therapy of bacteremia and endocarditis due to staphylococci and enterococci: New insights and evidence from the literature. J Infect Chemother21: 330-339.
- Barie PS, Wilson SE (2015) Impact of Evolving Epidemiology on Treatments for Complicated Skin and Skin Structure Infections: The Surgical Perspective. J Am CollSurg220,:105-116.e6.
- Morata L, Mensa J, Soriano A (2015)New antibiotics against gram-positives: present and future indications.CurrOpinPharmacol24: 45-51.
- Brown P, Dawson MJ (2016) A Perspective on the Next Generation of Antibacterial Agents Derived by Manipulation of Natural Products. In: Lawton G, Witty DR(Eds), Progress in Medicinal Chemistry. Elsevier.
- Dryden M, Andrasevic AT, Bassetti M, Bouza E, Chastre J, et al. (2015) Managing skin and soft-tissue infection and nosocomial pneumonia caused by MRSA: a 2014 follow-up survey.Int J Antimicrob Ag 45: S1-S14.
- Que YA, Moreillon P(2015) Staphylococcus aureus (Including Staphylococcal Toxic Shock Syndrome). In: John E. Bennett JE, Dolin R, Blaser MJ (Eds), Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. (8th Edition), Content Repository Only, Philadelphia.
- Padberg S (2015) Anti-infective Agents. In:Schaefer C, Peters PWJ, Miller RK (Eds), Drugs During Pregnancy and Lactation. (3rd Edition), Academic Press, San Diego.
|